Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep;23(4):333-40.
doi: 10.1016/j.jsps.2013.12.012. Epub 2013 Dec 24.

Diabetes treatment: A rapid review of the current and future scope of stem cell research

Affiliations
Review

Diabetes treatment: A rapid review of the current and future scope of stem cell research

Sheriff Sheik Abdulazeez. Saudi Pharm J. 2015 Sep.

Abstract

Diabetes mellitus is a major health concern of the developing and developed nations across the globe. This devastating disease accounts for the 5% deaths around the world annually. The current treatment methods do not address the underlying causes of the disease and have severe limitations. Stem cells are unique cells with the potential to differentiate into any type of specialized cells. This feature of both adult and embryonic stem cells was explored in great detail by the scientists around the world and are successful in producing insulin secreting cells. The different type of stem cells (induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs) and adult stem cells) proves to be potent in treating diabetes with certain limitations. This article precisely reviews the resources and progress made in the field of stem cell research for diabetic treatment.

Keywords: Diabetes; Induced pluripotency; Stem cells; β-Cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Self renewal and differentiation potential of the stem cells.
Figure 2
Figure 2
Pluripotent stem cell forms the cells of all there germ layers.
Figure 3
Figure 3
Different types of stem cell resources with a potential to be developed into insulin secreting cells.
None

References

    1. Adler R. Curing blindness with stem cells: hope, reality, and challenges. Adv. Exp. Med. Biol. 2008;613:3–20. - PubMed
    1. Alipio Z., Liao W., Roemer E.J., Waner M., Fink L.M., Ward D.C., Ma Y. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β-like cells. Proc. Natl. Acad. Sci. USA. 2010;107:13426–13431. - PMC - PubMed
    1. Assady S., Maor G., Amit M., Itskovitz-Eldor J., Skorecki K.L., Tzukerman M. Insulin production by human embryonic stem cells. Diabetes. 2001;50:1691–1697. - PubMed
    1. Atkinson M.A., Eisenbarth G.S. Type I diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221–229. - PubMed
    1. Ber I., Shternhall K., Perl S., Ohanuna Z., Goldberg I., Barshack I., Benvenisti-Zarum L., Meivar-Levy I., Ferber S. Functional, persistent, and extended liver to pancreas transdifferentiation. J. Biol. Chem. 2003;278:31950–31957. - PubMed

LinkOut - more resources